PER 1.41% 7.0¢ percheron therapeutics limited

Ann: ANP meeting with US FDA granted for ATL1102 in DMD, page-34

  1. 3,233 Posts.
    lightbulb Created with Sketch. 267
    Now it is clear you don’t know the difference between company’s scientific achievements = very remarkable especially lately on DMD and leadership that supposed to maximise those scientific results that should have reflected on sp level in all these years = lack of charisma,poor P.R. skill failing in keeping sh/market up to date..........
    Anyway I now got a clear impression it is waste of time to discuss with you. Good luck with your (and mine) holding.
    Last edited by imperatore: 15/02/21
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
-0.001(1.41%)
Mkt cap ! $63.10M
Open High Low Value Volume
7.1¢ 7.1¢ 6.9¢ $34.01K 486.5K

Buyers (Bids)

No. Vol. Price($)
2 132919 6.9¢
 

Sellers (Offers)

Price($) Vol. No.
7.3¢ 78000 1
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.